Severe sepsis in autologous stem cell transplant recipients: Microbiological aetiology, risk factors and outcome

References

• Gratwohl A. Activity survey and historical perspective of autologous stem cell transplantation in Europe. Semin Hematol 2007; 44: 220–6
   PubMed Web of Science ®Google Scholar
• Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D. Joint Accreditation Committee of the International Society for Cellular Therapy ISCT; European Group for Blood and Marrow Transplantation EBMT. The EBMT activity survey 2006 on haematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant 2008; 41: 687–705
   PubMed Web of Science ®Google Scholar
• Jantunen E, Itälä M, Lehtinen T, Kuittinen O, Koivunen E, Leppä S, et al. Early treatment-related mortality in adult autologous stem cell transplant recipients: a nationwide survey of 1482 transplanted patients. Eur J Haematol 2006; 76: 245–50
   PubMed Web of Science ®Google Scholar
• Puig N, de la Rubia J, Jarque I, Salavert M, Montesinos P, Sanz J, et al. A study of incidence and characteristics of infections in 476 patients from a single centre undergoing autologous blood stem cell transplantation. Int J Hematol 2007; 86: 186–92
   PubMed Web of Science ®Google Scholar
• Ramphal R. Changes in the aetiology of bacteraemia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004; 39: 25–31
   PubMed Web of Science ®Google Scholar
• Kanamaru A, Tatsumi Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis 2004; 15: 7–10
   Web of Science ®Google Scholar
• Centers for Disease Control and Surveillance. Guidelines for preventing opportunistic infections among haematopoietic stem cell recipients: recommendations of the CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow transplantation. MMWR Morb Mortal Wkly Rev 2000;49:1–125.
   PubMedGoogle Scholar
• Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–51
   PubMed Web of Science ®Google Scholar
• Sepkowitz KA. Antibiotic prophylaxis in patients receiving haematopoietic stem cell transplant. Bone Marrow Transplant 2002; 29: 367–71
   PubMed Web of Science ®Google Scholar
• Lo N, Cullen M. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider. Hematol Oncol 2006; 24: 120–5
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Kuittinen T, Matinlauri I, Koivula I, Nousiainen T, Jantunen E. Neutropenic fever and severe sepsis in adult AML patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma 2008; 49: 495–501
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis definitions conference. Crit Care Med 2003; 31: 1250–6
   PubMed Web of Science ®Google Scholar
• Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–74.
   PubMed Web of Science ®Google Scholar
• Otsuji S, Shibata H, Umeda M. Turbidimetric immunoassay of serum C-reactive protein. Clin Chem 1982; 28: 2121–24
   PubMed Web of Science ®Google Scholar
• Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen J-M, Dybdahl B, et al. A multicentre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility. Scand J of Infect Dis 2005; 37: 455–64
   PubMed Web of Science ®Google Scholar
• Slavin MA, Grigg AP, Schwarer AP, Szer J, Spencer A, Sainani A, et al. A randomized comparison of empiric or pre-emptive antibiotic therapy after haematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 157–63
   PubMed Web of Science ®Google Scholar
• Cherif H, Kronvall G, Björkholm M, Kalin M. Bacteraemia in hospitalized patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-y period without antibacterial prophylaxis. Hematol J 2003; 4: 420–6
   PubMedGoogle Scholar
• Craig M, Cumpston AD, Hobbs GR, De Vetten MP, Sarwari AR, Ericson SG. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a haematological malignancy and transplantation unit. Bone Marrow Transplant 2007; 39: 477–82
   PubMed Web of Science ®Google Scholar
• Leibovici L, Paul M, Cullen M, Bucaneve G, Grafter-Gvili A, Fraser A, et al. Antibiotic prophylaxis in neutropenic patients. Cancer 2006; 107: 1743–51
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Herbrecht R, Buzyn A, Leverger G, Leclercq R, Nitenberg G, et al. Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica 2005; 90: 1102–9
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Buzyn-Lévy A, Leverger G, Herbrecht R, Hunault M, Leclercq R, et al. Epidemiology and risk factors for Gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003; 36: 149–58
   PubMed Web of Science ®Google Scholar
• Naeem N, Reed MD, Creger RJ, Youngner SJ, Lazarus HM. Transfer of the haematopoietic stem cell transplant patient to the intensive care unit: does it really matter?. Bone Marrow Transplant 2006; 37: 119–33
   PubMed Web of Science ®Google Scholar
• Fujii K, Aoyama M, Shinagawa K, Matsuo K, Takenaka K, Ikeda K, et al. Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. Int J Hematol 2002; 76: 186–91
   PubMed Web of Science ®Google Scholar
• Kuittinen T, Husso-Saastamoinen M, Sipola P, Vuolteenaho O, Ala-Kopsala M, Nousiainen T, et al. Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplant 2005; 36: 1077–82
   PubMed Web of Science ®Google Scholar
• Karlsson S, Pettilä V, Tenhunen J, Lund V, Hovilehto S, Ruokonen E for the Finnsepsis Study Group. Vascular endothelial growth factor in severe sepsis and septic shock. Anesth Analg 2008;6:1820–6.
   Google Scholar